NLN expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.51569999673873E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.38720000000004E-05 |
Normal-vs-Stage2 |
8.946300E-02 |
Normal-vs-Stage3 |
1.32940003449988E-09 |
Normal-vs-Stage4 |
4.34890000000632E-05 |
Stage1-vs-Stage2 |
8.549000E-01 |
Stage1-vs-Stage3 |
3.918900E-03 |
Stage1-vs-Stage4 |
1.301590E-01 |
Stage2-vs-Stage3 |
1.237420E-01 |
Stage2-vs-Stage4 |
2.952000E-01 |
Stage3-vs-Stage4 |
5.536800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.08119999953082E-07 |
Normal-vs-AfricanAmerican |
4.623100E-04 |
Normal-vs-Asian |
6.216200E-02 |
Caucasian-vs-AfricanAmerican |
6.600600E-01 |
Caucasian-vs-Asian |
9.129600E-01 |
AfricanAmerican-vs-Asian |
7.738000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.21220000493372E-08 |
Normal-vs-Female |
3.96150000000484E-05 |
Male-vs-Female |
3.035000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.33679999999526E-05 |
Normal-vs-Age(41-60Yrs) |
5.19320000003098E-07 |
Normal-vs-Age(61-80Yrs) |
2.06579999999512E-05 |
Normal-vs-Age(81-100Yrs) |
3.68889999999844E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.026800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.251200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.349400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.654000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.226000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.014800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.350200E-01 |
Normal-vs-Grade 2 |
3.83910000000265E-05 |
Normal-vs-Grade 3 |
2.2154000000052E-06 |
Normal-vs-Grade 4 |
4.50579999977663E-08 |
Grade 1-vs-Grade 2 |
8.233200E-01 |
Grade 1-vs-Grade 3 |
6.855000E-01 |
Grade 1-vs-Grade 4 |
1.785580E-01 |
Grade 2-vs-Grade 3 |
6.525400E-01 |
Grade 2-vs-Grade 4 |
2.082200E-02 |
Grade 3-vs-Grade 4 |
3.522500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.041300E-03 |
Normal-vs-ccB subtype |
5.89470000034176E-07 |
ccA subtype-vs-ccB subtype |
5.970300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.45109999969162E-07 |
Normal-vs-N1 |
8.799800E-02 |
N0-vs-N1 |
9.024400E-01 |
|
|